Skip to main content

Table 2 Frequency distribution of domains and tracer items readiness indicators as well as posterior inclusion probabilities of general and malaria-specific tracers estimated from the Bayesian variable selection. Tracers with inclusion probabilities higher than 50% were selected for the MCA

From: Constructing a malaria-related health service readiness index and assessing its association with child malaria mortality: an analysis of the Burkina Faso 2014 SARA data

Domain/tracer items

Medical centres (n = 112)

Peripheral health centres (n = 546)

Availability (%)

Posterior inclusion probability2 (%)

Availability (%)

Posterior inclusion probability (%)

General service

 Basic amenities1

39 (34.8)

 

6 (1.1)

 

  Power (electric or solar device)

86 (76.8)

8.5

362 (66.3)

21.4

  Improved water source inside or within the ground of the facility

110 (98.2)

3

476 (87.2)

60.9

  Room with auditory and visual privacy for patient consultations

81 (72.3)

100

284 (52.0)

39.2

  Access to adequate sanitation facilities for clients

109 (97.3)

519 (95.1)

  Communication equipment (phone or SW radio)

111 (99.1)

535 (98.0)

  Facility has access to computer with E-mail/Internet access

56 (50.0)

6.9

10 (1.8)

  Emergency transportation

106 (94.6)

61.7

515 (94.3)

88.0

 Basic equipment

72 (64.2)

 

264 (48.4)

 

  Adult scale

108 (96.4)

527 (96.5)

  Child scale

82 (73.2)

13.2

428 (78.4)

15.1

  Thermometer

112 (100)

544 (99.6)

  Stethoscope

112 (100)

540 (98.9)

  Blood pressure apparatus

109 (97.3)

533 (97.6)

  Light source

92 (82.1)

100

349 (63.9)

16.2

 Standard precautions for infection prevention

52 (46.4)

 

223 (40.8)

 

  Safe final disposal of sharp materials

85 (75.9)

84.7

422 (77.3)

28.2

  Safe final disposal of infectious wastes

82 (73.2)

62.9

336 (61.5)

18.2

  Appropriate storage of sharp waste

110 (98.2)

535 (98.0)

  Appropriate storage of infectious waste

103 (92.0)

85.3

494 (90.5)

50.8

  Disinfectant

111 (99.1)

544 (99.6)

  Single use (standard disposable or auto-disable syringes)

111 (99.1)

543 (99.5)

  Soap and running water or alcohol based hand rub

105 (93.8)

33.6

518 (94.9)

99.2

  Latex gloves

100 (89.9)

56.1

499 (91.4)

99.3

  Guidelines for standard precautions

98 (87.5)

98.3

469 (85.9)

21.2

 Diagnostic capacity

37 (33.0)

 

3 (0.6)

 

  Haemoglobin

72 (64.3)

100

9 (1.7)

  Blood glucose

50 (44.6)

48.2

6 (1.1)

  Malaria diagnostic capacity

101 (90.2)

17.5

467 (85.5)

21.3

  Urine dipstick-protein

103 (92.0)

49.0

501 (91.8)

50.1

  Urine dipstick-glucose

104 (92.9)

80.6

491 (89.9)

31.4

  HIV diagnostic capacity

106 (94.6)

32.9

512 (93.8)

39.8

  Urine test for pregnancy

96 (85.7)

26.0

412 (75.5)

42.3

 Essential medicines

2 (0.1)

 

0 (0)

 

  Amoxicillin tablet

101 (90.2)

40.6

523 (95.8)

  Ampicillin for inject

104 (92.9)

21.7

519 (95.1)

  Gentamicin injectable

101 (90.2)

77.7

472 (86.5)

30.3

  Oxytocin injectable

98 (87.5)

100

502 (91.9)

77.8

  Amoxicillin dispersible

94 (83.9)

10.6

475 (87.0)

20.1

  Oral rehydration solution (ORS)

95 (84.8)

16.8

476 (87.2)

20.3

  Zinc

77 (68.8)

100

418 (76.6)

14.9

  Aspirin

94 (83.9)

100

377 (69.1)

19.6

  Magnesium sulfate

78 (69.6)

100

121 (22.2)

20.9

  Amlodipine

25 (22.3)

100

12 (2.2)

  Enalapril

20 (17.9)

26.1

6 (1.1)

  Insulin injectable

8 (7.1)

35.9

5 (0.9)

  Betablockers

20 (17.9)

100

8 (1.5)

  Beclomethasone inhaler

14 (12.5)

100

9 (1.7)

  Ceftriaxone injection

103 (92.0)

93.8

492 (90.1)

58.4

  Thiazidic

25 (22.3)

14.2

41 (7.5)

50.6

  Glibenclamide tablet

39 (34.8)

100

10 (1.8)

  Metformin

41 (36.6)

22.9

9 (1.7)

  Omeprazole

65 (58.0)

10.1

110 (20.2)

20.2

  Salbutamol inhaler

86 (76.8)

63.3

288 (52.8)

24.9

  Carbamazepine

28 (25.0)

69.9

0 (0.0)

  Haloperidol

27 (24.1)

96.6

0 (0.0)

  Simvastatin

4 (3.6)

  

  Fluoxetin

3 (2.7)

 

Malaria-specific service

 Staff and guidelines

41 (45.5)

 

313 (57.7)

 

  Guidelines for diagnosis and treatment of malaria

105 (93.8)

22.4

536 (98.2)

  Guidelines for intermittent preventive treatment

75 (67.0)

13.0

481 (88.1)

31.1

  Staff trained in malaria diagnosis and treatment

79 (70.5)

97.5

453 (83.0)

40.9

  Staff trained in intermittent preventive treatment

74 (66.1)

100

370 (67.8)

58.9

Diagnostics

101 (90.2)

 

467 (85.5)

 

  Malaria diagnostic capacity (rapid diagnostic test/thin blood film)

101 (90.2)

17.5

467 (85.5)

21.3

 Medicines and commodities

21 (18.8)

 

172 (31.5)

 

  First-line antimalarial in stock (artemether+lumefantrine, artesunate+amodiaqune)

99 (88.4)

58.8

526 (96.3)

  Paracetamol cap/tab

104 (92.9)

100

418 (76.2)

34.6

  Intermittent preventive treatment of malaria in pregnancy (IPTp) drug (sulfadoxine pyrimethamine)

62 (55.4)

28.4

356 (65.2)

17.1

  ITNs

29 (25.9)

73.2

185 (33.9)

26.2

  1. 1Domain readiness indicators were defined as availability of all tracer items belonging to the domain
  2. 2Posterior inclusion probability: gives the probability of the tracer to be included in the final model and it is calculated by the proportion of all possible models in the variable selection procedure that include the specific tracer. For example, the posterior inclusion probability of 21.4 estimated for the power tracer indicates that this tracer was included in 21.4% of all possible models generated from all general services-related tracers
  3. 3Item not included in the variable selection procedure due to low relative frequency i.e. < 5%